RecruitingNot Applicable

US & HILT Comparative Effect on Neuropathic Pain, Strength & QOF in Diabetic Foot

Pakistan46 participantsStarted 2024-02-01

Plain-language summary

To compare the effects of therapeutic ultrasound and high intensity laser therapy on neuropathic pain , strength and quality of life in patients with diabetic foot

Who can participate

Age range

50 Years – 75 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with type 2 diabetes. * Diabetic Patients of age 50 to 75 years. * Diabetic patient of Both genders * Diagnosed Diabetes Mellitus with at least 7 years of duration * Distal symmetrical or asymmetrical polyneuropathy with pain in the lower extremity for ≥6 months * DNS (Diabetic neuropathy symptoms questionnaire) score greater than 4 (90 percent probability of neuropath Exclusion Criteria: * Pregnant females * Lower limb Amputated patients * History or evidence of neurological disorders other than peripheral neuropathy associated with Diabetes mellitus. * Evidence of musculoskeletal dysfunctions like scoliosis, lumbar disc prolapses and lumbar spine associated radiculopathy. * History of any low back surgeries and lower limb surgeries * Patient with malignancy. Patient with epilepsy * Patient with hemophilia * Patient with pacemaker, metal implants prosthesis and internal fixation screws. * Patient with severe cervical and lumbar neuropathy, rheumatoid arthritis, hereditary neuropathy * Patient with a history of neurosurgery

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

michigan neuropathy screening instrument

Timeframe: 8th week

foot and ankle disability index

Timeframe: 8th week

Trial details

NCT IDNCT06479577

SponsorRiphah International University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-07-01

Contact for this trial

Imran Amjad, Phd

03324390125 Imran.amjad@riphah.edu.pk

View on ClinicalTrials.gov More Diabetic Foot trials

Who can participate

Age range

50 Years – 75 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.